5 results
management empiric guidelines hcap acquired azithromycin cap clarithromycin community diagnosis erythromycin hospitalacquiredpneumonia idsa macrolides mdro outpatient overview regimen review riskfactors
Table 4. Recommended Initial Empiric Antibiotic Therapy for Hospital-Acquired Pneumonia (Non-Ventilator-Associated Pneumonia) #Management #InfectiousDiseases #Empiric #Antibiotics
Initial Empiric Antibiotic ... ) #Management #InfectiousDiseases ... #Empiric #Antibiotics ... #HAP #HCAP #HospitalAcquiredPneumonia ... #IDSA2016
IDSA Risk Factors for Multidrug-Resistant Pathogens #Diagnosis #Management #InfectiousDiseases #MDRO #RiskFactors #HAP #VAP #HCAP #IDSA2016 #Guidelines
Diagnosis #Management #InfectiousDiseases ... #RiskFactors #HAP ... #VAP #HCAP #IDSA2016 ... #Guidelines #Pneumonia
Table 3. Suggested Empiric Treatment Options for Clinically Suspected Ventilator-Associated Pneumonia in Units Where Empiric Methicillin-Resistant
Ventilator-Associated Pneumonia ... Appropriate #Management #InfectiousDiseases ... #Empiric #Antibiotics ... #VAP #VentilatorAssociatedPneumonia ... #IDSA2016
Outpatient Treatment of with Community-Acquired Pneumonia (CAP) No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Community-Acquired Pneumonia ... (CAP) No comorbidities ... IDSA #Outpatient #CAP ... #Antibiotics #Treatment ... Management #Guidelines #pharmacology
Macrolides - Erythromycin, Clarithromycin, Azithromycin - Antibiotics Class Overview 50S Ribosomal Inhibitor (PO and IV) Spectrum: Atypical organisms
Azithromycin - Antibiotics ... community-acquired pneumonia ... Ceftriaxone for CAP ... #Pharmacology #Antibiotics
No results found for "anion gap pneumonia pharmacology antibiotics antifungal idsa2016 hap vap infectiousdiseases"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #anion #gap #pneumonia #pharmacology #antibiotics #antifungal #idsa2016 #hap #vap #infectiousdiseases